Advertisement

x

Mathews Journal of Cancer Science

2474-6797

Publication Ethics

Mathews Open Access Journals follow certain ethical standards to make sure high-quality scientific publications, to attain public confidence in scientific findings.

Plagiarism/ Duplicate Submission: Mathews Open Access Journals firmly encourages original manuscripts and must not use the words, figures, or ideas of others without attribution. All sources must be cited at the point they are used, and reuse of wording must be limited and be attributed or quoted in the text. The content should not be submitted/ published elsewhere with other publishing groups. Our quality control teams check for the plagiarism through software to detect the overlapping of content and similar text in submitted manuscripts. Manuscripts that are found to have been plagiarized from a manuscript by other authors, whether published or unpublished, will be rejected and the authors may incur sanctions. Any published articles may need to be corrected or retracted.

Data Fabrication and Falsification: If the submitted manuscripts are found to have either fabricated or falsified research work, i.e. methods, experimental results, including the manipulation of images will be immediately rejected.

Conflicts of Interest: Authors must declare all potential interests in a ‘Conflicts of interest’ section, which should explain why the interest may be a conflict. If there are none, the authors should state “The author(s) declare(s) that there are no conflicts of interest regarding the publication of this paper.” Submitting authors are responsible for coauthors declaring their interests.

Human and Animal Rights: Ethical clearance documents need to be provided if applicable. The work involving animal models and human volunteers need to submit the necessary statements.

In the above publication ethical cases if the violations are found, the editorial office is authorized to take action accordingly.

Recently Published Articles
Research Article

Interactive Treatment Planning in High Dose-Rate Brachytherapy for Gynecological Cancer

Published : 03rd June 2022
Authors : Huan Liu1, Chenyang Shen2, Peter Klages2, Kevin Albuquerque2, Chang M Ma1*, Xun Jia2*
Citation : Chang-Ming Ma, Xun Jia, et al. (2022). Interactive Treatment Planning in High Dose-Rate Brachytherapy for Gynecological Cancer. Mathews J Cancer Sci. 7(2):31.

Case Report

Is Anaplastic Oligodendroglioma Prone to Extracranial Metastasis? A Case Report and Review of Literature

Published : 30th January 2022
Authors : Yanjun Zhang*#, Canliang Yuan*, Dequan Yu
Citation : Zhang Y, et al. (2022). Is Anaplastic Oligodendroglioma Prone to Extracranial Metastasis? A Case Report and Review of Literature. Mathews J Cancer Sci. 7(1):30.

Editorial note

On the Definition of Sievert and Its SI Unit

Published : 30th December 2021
Author : C-M Charlie Ma
Citation : Ma C-M. (2021). On the Definition of Sievert and Its SI Unit. Mathews J Cancer Sci. 6(1):29.

Research Article

A Clinical Study on Pulsed Low Dose Rate Radiation Therapy for Recurrent Cancers

Published : 21st December 2021
Authors : X Tong*, FS Luo, GR Yang, DP Wang, X Song, Y Chen, S Wu, N Zhang, QQ Xu, T Zhang, and J Li
Citation : Tong X. (2021). A Clinical Study on Pulsed Low Dose Rate Radiation Therapy for Recurrent Cancers. Mathews J Cancer Sci. 6(1):28.

Review Article

Clinical Applications of Pulsed Low Dose-Rate Radiation Therapy

Published : 21st May 2021
Author : Lili Chen
Citation : Chen L. (2021). Clinical Applications of Pulsed LowDose-Rate Radiation Therapy. Mathews J Cancer Sci. (6)1:27.

Research Article

The Role of Temozolomide-Irinotecan in Doxorubicin- Resistant Cell Lines of Recurrent Ewing’s Sarcoma, in A Patient Derived Orthotopic Xenograft (PDOX) with EWS-ERG Fusion and CDKN2A Loss: What Impact the Combination has in Real Life Practice?

Published : 08th October 2020
Authors : Maher Salamoon¹, Mehdi Balti², Bertrand Farnault³, Maher Saifo4, Ali Mahmoud5, Ahmad Khatib6, Manal Daghlawi7, Taisir Husein8, Mazen Kenj9, and Khaled Ghanem10
Citation : Salamoon M. (2020). The Role of Temozolomide-Irinotecan in Doxorubicin-Resistant Cell Lines of Recurrent Ewing’s Sarcoma, in A Patient Derived Orthotopic Xenograft (PDOX) with EWS-ERG Fusion and CDKN2A Loss: What Impact the Combination has in Real Life Practice?. Mathews J Cancer Sci. (5)1: 21.

Indexed
Root Indexing
J Gate
Scientific Indexing Services
Scilit
WolrdCat
Directory of Research Journals Indexing
Genamics JournalSeek
International Scientific Indexing
International Committee of Medical Journal Editors
CiteFactor
Subscribe

Subscribe to our RSS feed, be in touch with our articles, news, videos, reebies.

Antispam Code Generate new code

Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com